Currently, there are 115.86M common shares owned by the public and among those 114.29M shares have been available to trade.
The company’s stock has a 5-day price change of 26.96% and 9.60% over the past three months. EVH shares are trading -52.42% year to date (YTD), with the 12-month market performance down to -6.67% lower. It has a 12-month low price of $7.06 and touched a high of $33.63 over the same period. EVH has an average intraday trading volume of 2.28 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 26.51%, 17.67%, and -25.40% respectively.
Institutional ownership of Evolent Health Inc (NYSE: EVH) shares accounts for 108.95% of the company’s 115.86M shares outstanding.
It has a market capitalization of $1.23B and a beta (3y monthly) value of 0.88. The earnings-per-share (ttm) stands at -$1.22. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.73% over the week and 4.94% over the month.
Earnings per share for the fiscal year are expected to decrease by -13.89%, and 67.45% over the next financial year. EPS should shrink at an annualized rate of 25.00% over the next five years, compared to 25.98% over the past 5-year period.
Looking at the support for the EVH, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on January 10, 2025, with the firm’s price target at $15. BTIG Research coverage for the Evolent Health Inc (EVH) stock in a research note released on December 03, 2024 offered a Buy rating with a price target of $29. Stephens was of a view on November 08, 2024 that the stock is Equal-Weight, while KeyBanc Capital Markets gave the stock Overweight rating on October 11, 2024, issuing a price target of $35. Truist on their part issued Buy rating on August 09, 2024.
